SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Shalby

BSE: 540797 29 Jun 2025
Healthcare
₹ 180.2
Shalby Limited specializes in Hospital within the Healthcare sector.

Shalby - Share Price & Details

Market Cap
₹1,977
High /Low
325.0 / 177.0
Stock P/E
1,030
Book Value
₹91.9
Dividend Yield
0.66
ROCE
6.61
ROE
₹0.19
Face Value
10.0
PEG Ratio
-25.0
EVEBITDA
₹15.1
Debt
476
CMP / FCF
-119.0
Debt to equity
₹0.48
NP Ann
1.92
High price all time
340.0
Piotroski score
₹3.0
Graham Number
34.5
No. Eq. Shares
10.8
Net CF
₹7.60
Net profit
1.92
Price to book value
1.99
Interest Coverage
₹2.44
Low price all time
40.0
Industry PE
60.4
Reserves
₹885
Free Cash Flow
₹-74.4

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Shalby LimitedNANANANA1,9771,030
Windlas Biotech Limited2076.46162.852027.057.69184830.3
Sigachi Industries LimitedNANANANA182526.2

Peer Comparison Chart


About Shalby

Shalby Limited, with Security Code 540797, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Shalby Ltd. Faces Persistent Decline Amidst Weak Financial Performance and Market Confidence

(10 May 2025)
Shalby Ltd., a small-cap company in the Hospital & Healthcare Services sector, has reached a new 52-week low and has underperformed its sector.
Read more →

Rare Craniosynostosis Surgery Successfully Done In Surat Shalby Hospital, Marking A Medical Milestone For South Gujarat

(04 May 2025)
Surat (Gujarat) [...
Read more →

Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India

(30 Apr 2025)
Monogram's mBôs TKA System approved for 102-patient clinical trial in India. Partnership with leading orthopedic hospital group Shalby.
Read more →

Major Breakthrough: Monogram's Robotic Surgery System Gets Green Light for 102-Patient Trial in India

(29 Apr 2025)
Monogram partners with leading Shalby Hospitals for groundbreaking robotic knee surgery trial in India. First surgeries expected within 90...
Read more →

Shalby slides after reporting net loss of Rs 2 cr in Q3

(04 Feb 2025)
Shalby slipped 3.96% to Rs 209.55 after the company reported a consolidated net loss of Rs 1.81 crore for Q3 FY25, compared to a net profit of Rs 19.07 crore...
Read more →

Briefs: Morepen Laboratories, Glenmark Life Sciences, Gland Pharma and Shalby

(16 Jan 2025)
Morepen Laboratories approves hiving off of medical devices business. The Board of Directors of Morepen Laboratories Limited has considered...
Read more →